InterventionsHuman trial
Lean Mass Effects of Anti-GDF8 (Trevogrumab) ± Anti-Activin A (Garetosmab) in People Living with Obesity Treated with Semaglutide with or without Low Lean Mass at Baseline
ADA Scientific Sessions 2026 Abstract
The paper
CHAO J, TEMPLETON A, YAO Y et al.
ADA Scientific Sessions 2026 Abstract · 7 Jun 2026
Presented at ADA Scientific Sessions 2026 · Oral 1230-OR
